Arcutis

Arcutis

Focuses on medical dermatology, leveraging innovations in inflammation and immunology.

HQ location
Westlake Village, United States
Launch date
Market cap
$1.9b
Enterprise value
$1.8b
Share price
$15.49 ARQT
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*
N/A

$150m

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth--1517 %230 %69 %32 %34 %
EBITDA0000000000000000000000000000
% EBITDA margin-(8025 %)(382 %)(56 %)(11 %)3 %14 %
Profit0000000000000000000000000000
% profit margin-(8450 %)(440 %)(71 %)(18 %)5 %29 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue-4949 %186 %39 %---

Source: Company filings or news article, Equity research estimates

Notes (0)
More about Arcutis
Made with AI
Edit

Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development of innovative therapies for dermatological diseases. The company focuses on filling the innovation gap in medical dermatology by leveraging recent advancements in inflammation and immunology. Arcutis serves patients suffering from skin conditions such as psoriasis, eczema, and seborrheic dermatitis. Operating in the biopharmaceutical market, the company employs a business model centered around research and development, clinical trials, and commercialization of its proprietary drug formulations. Revenue is generated through the sale of these specialized therapies once they receive regulatory approval. The leadership team, which includes top dermatologists and a leading topical drug formulator, brings unparalleled expertise to the company's mission of becoming a leader in dermatological innovation.

Keywords: biopharmaceutical, dermatology, psoriasis, eczema, seborrheic dermatitis, inflammation, immunology, drug development, clinical trials, proprietary formulations.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Arcutis

Edit
Ducentis BioTherapeutics
ACQUISITION by Arcutis Sep 2022